Abstract:Spinal muscular atrophy (SMA), a degenerative motor neuron disease and a leading cause of infant mortality, is caused by loss of functional survival motor neuron (SMN) protein due to SMN1 gene mutation. Here, using mouse and cell models for behavioral and histological studies, we found that SENP2 (SUMO/sentrin-specific protease 2)-deficient mice developed a notable SMA-like pathology phenotype with significantly decreased muscle fibers and motor neurons. At the molecular level, SENP2 deficiency in mice did not affect transcription but decreased SMN protein levels by promoting the SUMOylation of SMN. SMN was modified by SUMO2 with the E3 PIAS2α and deconjugated by SENP2. SUMOylation of SMN accelerated its degradation by the ubiquitin-proteasome degradation pathway with the ubiquitin E1 UBA1 (ubiquitin-like modifier activating enzyme 1) and E3 ITCH. SUMOylation of SMN increased its acetylation to inhibit the formation of Cajal bodies (CBs). These results showed that SENP2 deficiency induced hyper-SUMOylation of the SMN protein, which further affected the stability and functions of the SMN protein, eventually leading to the SMA-like phenotype. Thus, we uncovered the important roles for hyper-SUMOylation of SMN induced by SENP2 deficiency in motor neurons and provided a novel targeted therapeutic strategy for SMA. KEY MESSAGES: SENP2 deficiency enhanced the hyper-SUMOylation of SMN and promoted the degradation of SMN by the ubiquitin-proteasome pathway. SUMOylation increased the acetylation of SMN to inhibit CB formation. SENP2 deficiency caused hyper-SUMOylation of SMN protein, which further affected the stability and functions of SMN protein and eventually led to the occurrence of SMA-like pathology.

An Essential Role of Small Ubiquitin-like Modifier (Sumo)-Specific Protease 2 in Myostatin Expression and Myogenesis*

SENP2 Regulates MEF2A De-Sumoylation in an Activity Dependent Manner.

SENP2 Promotes VSMC Phenotypic Switching Via Myocardin De-SUMOylation

Transforming Growth Factor-β-independent Regulation of Myogenesis by SnoN Sumoylation*

SUMO-specific protease 2 is essential for suppression of polycomb group protein-mediated gene silencing during embryonic development.

SUMOylation Activates Large Tumour Suppressor 1 to Maintain the Tissue Homeostasis During Hippo Signalling

Research progression on biologic function and effect of SUMO-specific proteinase

Enhanced desumoylation in murine hearts by overexpressed SENP2 leads to congenital heart defects and cardiac dysfunction

Ubc9 Expression is Essential for Myotube Formation in C2C12

Sumo-Specific Protease 1 Is Critical For Myeloid-Derived Suppressor Cell Development And Function

Regulation of Myostatin on the Growth and Development of Skeletal Muscle

Hyper-SUMOylation of SMN induced by SENP2 deficiency decreases its stability and leads to spinal muscular atrophy-like pathology

SUMO protease SENP1 deSUMOylates and stabilizes c-Myc

Myostatin: a novel insight into its role in metabolism, signal pathways, and expression regulation.

SUMO modification selectively regulates transcriptional activity of peroxisome-proliferator-activated receptor γ in C2C12 myotubes

Inhibition of Sesn2 has negative regulatory effects on the myogenic differentiation of C2C12 myoblasts

SUMO-specific Protease 1 Regulates Mitochondrial Biogenesis Through PGC-1α.

Sumo-Specific Protease 1 is Critical for Early Lymphoid Development Through Regulation of Stat5 Activation

SUMO-Specific Protease 1 is Essential for Stabilization of HIF1α During Hypoxia

[Sumo-Specific Protease 1 and Cancer].

Small Ubiquitin-Like Modifier (sumo) Protein-Specific Protease 1 De-Sumoylates Sharp-1 Protein and Controls Adipocyte Differentiation